Adaptimmune Therapeutics
ADAP
#9234
Rank
ยฃ54.61 M
Marketcap
ยฃ0.21
Share price
4.45%
Change (1 day)
-77.35%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ0.17 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's total liabilities are ยฃ0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Adaptimmune Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.19 B-6.55%
2022-12-31ยฃ0.20 B4.57%
2021-12-31ยฃ0.19 B142.16%
2020-12-31ยฃ80.63 M82.61%
2019-12-31ยฃ44.15 M87.78%
2018-12-31ยฃ23.51 M-59.34%
2017-12-31ยฃ57.83 M4.37%
2016-12-31ยฃ55.41 M
2015-06-30ยฃ26.47 M-15.08%
2014-06-30ยฃ31.17 M1095.83%
2013-06-30ยฃ2.6 M0.01%
2012-06-30ยฃ2.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ1.62 B 832.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.54 M-91.08%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.41 B 140.60%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ0.52 B 200.49%๐Ÿ‡บ๐Ÿ‡ธ USA